Citation Impact
Citing Papers
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
The natural history of renal carcinoma.
1983
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways.
2003 StandoutNobel
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Expanding indications for conservative renal surgery in renal cell carcinoma
1994
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
2003
Complications of Laparoscopic Surgery for Renal Masses: Prevention, Management, and Comparison with the Open Experience
2009
Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes
2002
Renal-Cell Carcinoma
1996 Standout
European guidelines for the diagnosis and treatment of pelvic girdle pain
2008 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
2016 Standout
Urethral Pain Among Prostate Cancer Survivors 1 to 14 Years After Radiation Therapy
2012
Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference
2009 StandoutNobel
von Hippel-Lindau disease
2003 Standout
Lack of Benefit for the Addition of Androgen Deprivation Therapy to Dose-Escalated Radiotherapy in the Treatment of Intermediate- and High-Risk Prostate Cancer
2010
Nephron-Sparing Surgery for Renal Cell Carcinoma: Detailed Analysis of Complications Over a 15-Year Period
2006
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Partial nephrectomy for renal cell carcinoma with a normal opposite kidney
1994
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology
2006 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Current controversies in nephron-sparing surgery for renal-cell carcinoma
1995
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Bovine Serum Albumin Glutaraldehyde for Completely Sutureless Laparoscopic Heminephrectomy in a Survival Porcine Model
2010 StandoutNobel
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Conservative Surgery for Renal Cell Carcinoma: A Single-Center Experience with 100 Patients
1989
NEPHRON SPARING SURGERY FOR RENAL TUMORS: INDICATIONS, TECHNIQUES AND OUTCOMES
2001
Laparoscopic Nephrectomy: Initial Case Report
1991 Standout
Partial Nephrectomy for Renal Cell Carcinoma
1987
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
1997 Standout
Mitochondrial respiratory capacity and Na+- and K+-dependent adenosine triphosphatase-mediated ion transport in the intact renal cell.
1981
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Laparoscopic Nephrectomy: Initial Case Report
2016 Standout
The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth
2009 Standout
Laparoscopic Radical versus Partial Nephrectomy: Assessment of Complications
2003
MANAGEMENT OF SMALL SOLITARY UNILATERAL RENAL CELL CARCINOMAS: IMPACT OF CENTRAL VERSUS PERIPHERAL TUMOR LOCATION
1998
The isolated perfused kidney: Possibilities, limitations and results
1975
Factors Influencing Adrenal Metastasis in Renal Cell Carcinoma
1994
Long-Term Results Following Partial Nephrectomy for Localized Renal Adenocarcinoma
1984
Defining High Risk Prostate Cancer With Risk Groups and Nomograms: Implications for Designing Clinical Trials
2006
Partial Nephrectomy for Renal Cell Carcinoma: Indications, Results and Implications
1991
SURGERY OF RENAL CELL CARCINOMA
1993
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors
2007 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Assessment of Risk Factors for Complications of Laparoscopic Partial Nephrectomy
2007
Altered Motor Control Strategies in Subjects With Sacroiliac Joint Pain During the Active Straight-Leg-Raise Test
2002
Works of H. Bertermann being referenced
GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer
2004
Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime
2005
Ultrasound Examination of Bladder and Prostate
1990
CO2-production by the isolated perfused rat kidney from14C-Labelled substrates
1973
Conservative Surgery of Renal Carcinoma: The EIRSS Experience
1981
Long-term outcome following high dose rate brachytherapy and external in men with localized prostate cancer. Does elective irradiation of the pelvic lymphatic compromise the feasibility of local dose escalation?
2000